Moreover, TMAO independently predicted all-cause mortality or reinfarction (death/MI) at 2 years but was not able to predict death/MI at 6 months in patients hospitalized for acute MI (n = 1079)
4,5 The FDA approval of Wegovy was based on the results of the STEP ( S emaglutide Tr eatment E ffect in P eople with Obesity) clinical trial program, which included four phase 3a clinical trials involving approximately 4,500 patients
Laboratory studies in cell and animal models of accelerated aging have shown that replenishing NAD+ can restore mitochondrial function and stimulate beneficial cellular recycling processes like mitophagy
GLP-1 and GIP pathways have effects beyond appetite
and received lecture fees from Boehringer Ingelheim, Eli Lilly, AstraZeneca, Merck Sharp & Dohme, Novo Nordisk and Bayer
Positive Rapid revenue growth and operating improvement : 2025 revenue increased to 720.1 million from 363.6 million, while operating loss narrowed to 136.3 million, showing strong commercial traction and better operating leverage
